Nail psoriasis, also known as psoriatic nail dystrophy, is due to psoriasis involving the nail matrix or nail bed, resulting in specific and non-specific clinical changes in the nail.
Nail psoriasis
Nail psoriasis
Nail psoriasis
Who gets nail psoriasis?
Nail psoriasis affects 90% of patients with chronic plaque psoriasis at some time in their life. It is more common in adults with a prevalence of up to 80%, compared to children in whom it has been reported in 7–13%. In the absence of skin or joint disease, psoriatic nail disease has been described in 5–10% of adults.
Psoriatic nail disease may be a risk factor the development of psoriatic arthritis and is often associated with prolonged severe cutaneous psoriasis.
Nail psoriasis can affect all races and age groups, and both sexes, although a male predominance has been reported in one large case series.
What causes nail psoriasis?
Psoriasis is a multifactorialsystemic disease including inflammation and epidermalhyperproliferation.
Nail psoriasis can involve the nail bed, nail matrix, hyponychium, and nail folds.
Theories include:
Activation of the antimicrobialpeptide LL-37 by Candida and the cytokine overflow theory
Increased expression of interleukin(IL)-10 in the affected nail bed compared to downregulation of IL-10 in psoriatic skin lesions
Koebnerisation of psoriasis in onychomycosis or nail trauma.
What are the clinical features of nail psoriasis?
Fingernails and toenails can be affected by nail psoriasis.
Psoriatic nail dystrophy can cause tenderness and pain, altered sense of fine touch, and difficulty picking up or manipulating objects such as shoelaces or buttons.
Association with psoriatic arthritis and metabolic syndrome
How is nail psoriasis diagnosed?
Nail psoriasis is usually diagnosed clinically in a patient with psoriatic arthritis and/or cutaneous psoriasis.
The severity of nail psoriasis can be estimated using the Nail Psoriasis Severity Index (NAPSI) in which each nail is divided into quadrants and scored for clinical signs to come up with a numerical score.
Nail clippings for fungal microscopy and culture should be taken as onychomycosis may precede or complicate psoriatic nail dystrophy, and immunosuppressive medications may be used in treatment.
A proximalnail matrix biopsy is occasionally needed to confirm the diagnosis of nail psoriasis, particularly in the absence of signs of psoriasis elsewhere or where only a single nail is affected and a tumour cannot be excluded by other means. Biopsy can lead to permanent nail deformity.
What is the differential diagnosis for nail psoriasis?
Nail psoriasis has a variable response to treatment. The visible response may take weeks or months due to slow growth of the nail plate, and relapses are common.
Psoriatic nail disease can fluctuate in severity over time and can resolve spontaneously.
Bibliography
Alves NCPOP, Moreira TA, Malvino LDS, et al. Onychomycosis in psoriatic patients with nail disorders: aetiological agents and immunosuppressive therapy. Dermatol Res Pract. 2020;2020:7209518. doi:10.1155/2020/7209518. Journal
Manhart R, Rich P. Nail psoriasis. Clin Exp Rheumatol. 2015;33(5 Suppl 93):S7–13. Journal
Pasch MC. Nail psoriasis: a review of treatment options. Drugs. 2016;76(6):675–705. doi:10.1007/s40265-016-0564-5. Journal
Schons KR, Knob CF, Murussi N, Beber AA, Neumaier W, Monticielo OA. Nail psoriasis: a review of the literature. An Bras Dermatol. 2014;89(2):312–17. doi:10.1590/abd1806-4841.20142633. PubMed Central
Ventura A, Mazzeo M, Gaziano R, Galluzzo M, Bianchi L, Campione E. New insight into the pathogenesis of nail psoriasis and overview of treatment strategies. Drug Des Devel Ther. 2017;11:2527–35. doi:10.2147/DDDT.S136986. Journal